Description

Basalog Refil is a monocomponent insulin medicine that contains Insulin Glargine Injection as its active ingredient. Insulin Glargine is a long-acting insulin analogue that is used to control high blood sugar levels in patients with diabetes mellitus. This injectable medication works by replacing the insulin that the body cannot produce or effectively use. It provides a steady level of insulin in the body, helping to regulate blood sugar levels throughout the day and night. Basalog Refil is administered subcutaneously (under the skin) and provides a continuous release of insulin to maintain glycemic control. Used in the treatment of type 1 and type 2 diabetes, Basalog Refil helps to improve glycemic control, reduce the risk of diabetes-related complications, and enhance overall quality of life for individuals with diabetes.

Additional information